<DOC>
	<DOC>NCT01151748</DOC>
	<brief_summary>Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma</brief_summary>
	<brief_title>Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma</brief_title>
	<detailed_description />
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Eye Neoplasms</mesh_term>
	<criteria>1. Patients diagnosed with advanced intraocular retinoblastoma (International Retinoblastoma Classification group D or E*). 2. Patients with tumor recurrence or vitreous seeding following completion of systemic chemotherapy or previous radiation therapy. 1. Congenital brain anomaly identified on MRI. 2. History of systemic coagulopathy. 3. Evidence of extra ocular retinoblastoma on clinical examination or neuroimaging.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>